Download
1 / 8
80 likes | 84 Views
The nerve repair & regeneration market is projected to reach US$ 12,514.06 million by 2028 from US$ 6,607.71 million in 2021; it is expected to grow at a CAGR of 9.7% from 2022 to 2028. Nerves, along with the brain and spinal cord, are the foundation of the nervous system. Nerve repair is a method that involves the exploration of the injured nerve and removal of injured tissue or scar from the nerve endings. <br><br>for more..<br>https://www.theinsightpartners.com/reports/nerve-repair-and-regeneration-market
E N D
Nerve Repair & Regeneration Market Global Analysis and Forecast to 2028 Published Date : Aug 2022 Email: sales@theinsightpartners.com
Email:sales@theinsightpartners.com Report Studies • Nerve Repair & Regeneration Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Lower Extremity and Upper Extremity) and End User (Hospitals & Clinics, Surgical Centers, and Others)
Email:sales@theinsightpartners.com Nerve Repair & Regeneration Market Value CAGR of 9.7% (2022 - 2028)
Email:sales@theinsightpartners.com Nerve Repair & Regeneration Market Overview • According to our latest study on “Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and Applications,” the market is expected to grow from US$ 6,607.71 million in 2021 to US$ 12,514.06 million by 2028; it is expected to grow at a CAGR of 9.7% from 2022 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. • Based on product, the nerve repair & regeneration market is bifurcated into neurostimulation & neuromodulation devices and biomaterials. Neurostimulation & neuromodulation devices segment is subsegmented into internal neurostimulation devices and external neurostimulation devices. Internal neurostimulation devices segment is further subsegmented into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation. External neurostimulation devices are also subsegmented into transcutaneous electrical nerve stimulation devices, transcranial magnetic stimulation devices, respiratory electrical stimulation devices.
Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Product {Neurostimulation & Neuromodulation Devices [Internal Neurostimulation Devices (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, Respiratory Electrical Stimulation Devices)] and Biomaterials [Nerve conduits, Nerve wraps, Nerve Connectors, and Other Biomaterials]} • By Application {Neurostimulation & Neuromodulation Applications [Internal neurostimulation & neuromodulation and External neurostimulation & neuromodulation], and Nerve Repair & Regeneration Applications [Direct Nerve Repair/Neurorrhaphy (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting (Autografts, Allografts, and Xenografts), and Stem cell therapy]}
Email:sales@theinsightpartners.com Company Profiles • Axogen Corporation • Boston Scientific Corporation • Integra LifeSciences • Medtronic • Abbott Laboratories • Stryker Corporation • Neuronetics • LivaNova PLC • Baxter • Polyganics BV Download Sample Here
Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).
THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com
